Skip to main content

Table 1 Baseline characteristics of the participants according to the glycemic status

From: Impaired fasting glucose and major adverse cardiovascular events by hypertension and dyslipidemia status: the Golestan cohort study

Variables

Total (N = 11,374)

NFG (N = 7421)

IFG (N = 2410)

DM(N = 1543)

p-value

Age (yr.)*

56.2 (0.1)

55.8 (0.1)

56.7 (0.2)

57.4 (0.2)

0.000

Sex (%M)

47.5%

48.4%

47.3%

43.2%

0.001

Smoking (%)

0.000

 Past

7.9%

7.8%

8.8%

7.2%

 Current

8.3%

9.2%

8.1%

4.3%

 Never

83.8%

83.0%

83.1%

88.5%

Alcohol (%)

2.7%

2.7%

2.6%

3.1%

0.7

Statin (%)†

4.2%

2.7%

3.7%

12.5%

0.007

BMI (kg/m2) *

27.1 (0.1)

26.5 (0.1)

27.6 (0.1)

29.2 (0.1)

0.000

WC (cm) *

94.6 (0.1)

92.5 (0.2)

96.2 (0.3)

101.9 (0.3)

0.000

W/H*

0.43 (0.001)

0.43 (0.001)

0.44 (0.002)

0.47 (0.002)

0.000

SBP (mmHg) *

125.7 (0.2)

123.9 (0.2)

128.0 (0.4)

130.7 (0.5)

0.000

DBP (mmHg) *

77.6 (0.1)

76.8 (0.1)

78.4 (0.3)

80.0 (0.3)

0.000

FBS (mmol/L) *

104.8 (0.4)

87.7 (0.1)

108.1 (0.1)

181.3 (1.8)

0.000

TG (mmol/L) *

138.7 (0.9)

126.9 (1.0)

145.5 (1.9)

185.2 (3.8)

0.000

Chol (mmol/L) *

203.5 (0.5)

200.3 (0.7)

207.1 (0.9)

213.3 (1.2)

0.000

LDL (mmol/L) *

118.2 (0.5)

116.4 (0.7)

121.1 (1.0)

122.3 (1.3)

0.000

HDL (mmol/L)

61.5 (0.6)

61.2 (0.3)

61.4 (0.8)

62.6 (3.7)

0.7

DLP %*

5189 (45.4%)

2945 (39.7%)

1202 (49.9%)

1040 (67.4%)

0.000

HTN %*

4517 (39.6%)

2578 (34.7%)

1064 (44.2%)

860 (55.7%)

0.000

  1. Data are presented as mean (standard error) and number (percentage)
  2. Comparing NFG and IFG groups: * p = 0.000, †p = 0.007
  3. BMI Body mass index, WC Waist circumference, W/H Waist to hip ratio, SBP Systolic blood pressure, DBP Diastolic blood pressure, FBS Fasting blood glucose, TG Triglyceride, Chol Cholesterol, LDL Low density lipoprotein, HDL High density lipoprotein, DLP Dyslipidemia, HTN Hypertension